This protein is overexpressed in PDAC and its silencing/targeting has been shown to affect cancer cell metabolism, proliferation and migration in vitro [8–11]; small compounds targeting myoferlin reduced the number of metastases and tumor size in mouse models [12–14]. This evidence concerns the gene MYOF and neoplasm.